Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 22.24 as of 2026-09-25T21:56:09.921Z.
Consensus retrieved: 2026-09-13T23:28:23.352Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-09-25T21:56:09.921Z.
Quote observation: 2026-09-25T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b3b90a7762a2408dbcb58fd8e58eb127fedbe776203d52c082fee2eaf22e35e3
Forward PE Ratio (22.24) = Dated Quote Price ($19.57) / Consensus Forward EPS ($0.88)
FORWARD PE RATIO
22.24
SECTOR MEDIAN · HEALTHCARE
18.73
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+18.74%
vs the sector median at left
NRC Health
Market Cap
$441.04M
Forward PE Ratio
22.24
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| NRC Health (NRC) | $441.04M | 22.24 |
| Shoulder Innovations, Inc. (SI)vs › | $352.34M | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $44.58M | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.11B | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.88B | 6.15 |
| TransMedics Group, Inc. (TMDX)vs › | $2.95B | 57.50 |
| Doximity, Inc. (DOCS)vs › | $4.93B | 19.58 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.22B | 20.34 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.83B | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.56B | N/A |
Trailing P/E
77.5
reported TTM EPS
Forward P/E
22.2
consensus EPS · fiscal year ending 2026-12-31
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $0.88 implies +252.0% EPS growth vs the reported trailing $0.25.
At the dated quote price of $19.57, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $0.88 | $0.88 – $0.88 | 1 | 22.2x |
| 2027-12-31 | $1.11 | $1.11 – $1.11 | 1 | 17.6x |
| 2028-12-31 | $1.16 | $1.16 – $1.16 | 1 | 16.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
